Nevro Corp Ownership
| NVRO Stock | USD 4.55 0.03 0.66% |
Shares in Circulation | First Issued 2013-09-30 | Previous Quarter 37 M | Current Value 37 M | Avarage Shares Outstanding 28.6 M | Quarterly Volatility 10.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Nevro |
Nevro Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nevro Corp recorded a loss per share of 1.87. The entity had not issued any dividends in recent years. The firm had 1:24 split on the 6th of November 2014. Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people. To find out more about Nevro Corp contact DKeith Grossman at 650 251 0005 or learn more at https://nevro.com.Besides selling stocks to institutional investors, Nevro Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nevro Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nevro Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nevro Corp Quarterly Liabilities And Stockholders Equity |
|
Nevro Corp Insider Trades History
Roughly 4.0% of Nevro Corp are currently held by insiders. Unlike Nevro Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nevro Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nevro Corp's insider trades
Nevro Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nevro Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nevro Corp backward and forwards among themselves. Nevro Corp's institutional investor refers to the entity that pools money to purchase Nevro Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 956.5 K | Assenagon Asset Management Sa | 2024-09-30 | 929.3 K | Geode Capital Management, Llc | 2024-09-30 | 835.2 K | Palo Alto Investors, Llc | 2024-09-30 | 750.4 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 732.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 675.5 K | Kent Lake Capital Llc | 2024-06-30 | 639.8 K | Citadel Advisors Llc | 2024-09-30 | 536.1 K | Balyasny Asset Management Llc | 2024-09-30 | 505.3 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 4.4 M | Armistice Capital, Llc | 2024-09-30 | 3.7 M |
Nevro Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nevro Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nevro Corp Outstanding Bonds
Nevro Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nevro Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nevro bonds can be classified according to their maturity, which is the date when Nevro Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Nevro Corp Corporate Filings
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 28th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Pair Trading with Nevro Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Nevro Stock
| 0.52 | DOCS | Doximity | PairCorr |
| 0.5 | VMD | Viemed Healthcare | PairCorr |
| 0.45 | FOXO | FOXO Technologies | PairCorr |
| 0.32 | ITGR | Integer Holdings Corp | PairCorr |
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 11.404 | Quarterly Revenue Growth (0.07) | Return On Assets (0.09) | Return On Equity (0.25) |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.